ConductScience.org, home

Paper2297481

Direct search methods in the optimisation of cancer chemotherapy regimens.

Berenbaum MC. Br J Cancer, 1990. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Direct search methods in the optimisation of cancer chemotherapy regimens. Papers, record 2297481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2297481

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Direct search methods in the optimisation of cancer chemotherapy regimens.
PubMed
Journal
Br J Cancer
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2019-05-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berenbaum MCM C

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Acetylcysteine
Animals
Cyclophosphamide
Doxorubicin
Drug Evaluation
Female
Ifosfamide
Leucovorin
Leukemia L1210
Methotrexate
Mice
Time Factors

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16604578Identical efficacy of methotrexate regimens with N5-methyltetrahydrofolate rescue or with leucovorin rescue for treatment of L1210 murine leukemia.Cancer Treat Rep1983https://conductscience.org/library/papers/6604578PubMed
24092891Application of response surface methods for evaluating the interactions of soman, atropine, and pralidioxime chloride.Fundam Appl Toxicol1985https://conductscience.org/library/papers/4092891PubMed
33531536Application of response-surface methodology to detect interactions of genotoxic agents in cultured mammalian cells.J Toxicol Environ Health1986https://conductscience.org/library/papers/3531536PubMed
43764910Estimation and analysis of the concentration-response surfaces associated with multiple-agent combinations.Toxicol Appl Pharmacol1986https://conductscience.org/library/papers/3764910PubMed
614117037EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA.Cancer Chemother Rep1964https://conductscience.org/library/papers/14117037PubMed
76807534Drug activity and therapeutic synergism in cancer treatment.Cancer Res1982https://conductscience.org/library/papers/6807534PubMed
84751256Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.Cancer Chemother Rep1973https://conductscience.org/library/papers/4751256PubMed
91212350Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.Br J Cancer1975https://conductscience.org/library/papers/1212350PubMed
10837368Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.Cancer Res1977https://conductscience.org/library/papers/837368PubMed
11408002On determining the levels of treatment to optimize the probability of a favorable response.Cancer Treat Rep1977https://conductscience.org/library/papers/408002PubMed
12304375Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models.Cancer Res1978https://conductscience.org/library/papers/304375PubMed
13647694Combination chemotherapy: arriving at optimal treatment levels by incorporating side effect constraints.Cancer Treat Rep1978https://conductscience.org/library/papers/647694PubMed
146783143Survival analysis of drug combinations using a hazards model with time-dependent covariates.Biometrics1980https://conductscience.org/library/papers/6783143PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
37737188Determination of a safe sedative combination of dexmedetomidine, ketamine and butorphanol for minor procedures in dogs by use of a stepwise optimization method.Acta Vet Scand2023https://conductscience.org/library/papers/37737188PubMed
26215579Combinations of dexmedetomidine and alfaxalone with butorphanol in cats: application of an innovative stepwise optimisation method to identify optimal clinical doses for intramuscular anaesthesia.J Feline Med Surg2016https://conductscience.org/library/papers/26215579PubMed
21624115Systematic quantitative characterization of cellular responses induced by multiple signals.BMC Syst Biol2011https://conductscience.org/library/papers/21624115PubMed
9108094Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9108094PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2297481

GET https://conductscience.org/api/papers/v1/2297481/authors